SVA Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$4.11M Sell
35,116
-3,161
-8% -$348K 0.36% 56
2020
Q3
$3.98M Sell
38,277
-20,437
-35% -$2.05M 0.39% 56
2020
Q2
$5.38M Sell
58,714
-64
-0.1% -$6.14K 0.57% 41
2020
Q1
$5.3M Buy
58,778
+1,376
+2% +$146K 0.61% 34
2019
Q4
$6.51M Sell
57,402
-1,679
-3% -$184K 0.6% 37
2019
Q3
$6.42M Sell
59,081
-498
-0.8% -$52K 0.63% 34
2019
Q2
$5.8M Sell
59,579
-16,044
-21% -$1.46M 0.57% 39
2019
Q1
$6.89M Buy
75,623
+2,864
+4% +$256K 0.67% 36
2018
Q4
$6.62M Buy
72,759
+4,421
+6% +$413K 0.74% 32
2018
Q3
$6.72M Buy
68,338
+2,432
+4% +$225K 0.68% 40
2018
Q2
$5.64M Buy
65,906
+16,387
+33% +$1.37M 0.61% 48
2018
Q1
$3.85M Sell
49,519
-2,700
-5% -$223K 0.48% 59
2017
Q4
$4.22M Buy
52,219
+2,700
+5% +$216K 0.49% 53
2017
Q3
$3.85M Buy
49,519
+89
+0.2% +$7.39K 0.48% 59
2017
Q2
$4.39M Buy
49,430
+892
+2% +$75.2K 0.57% 55
2017
Q1
$3.91M Sell
48,538
-603
-1% -$47.1K 0.53% 58
2016
Q4
$3.5M Sell
49,141
-3,798
-7% -$298K 0.52% 63
2016
Q3
$4.57M Buy
52,939
+4,226
+9% +$368K 0.71% 47
2016
Q2
$4.23M Buy
48,713
+355
+0.7% +$28.7K 0.68% 46
2016
Q1
$3.63M Buy
48,358
+3,550
+8% +$267K 0.6% 53
2015
Q4
$3.45M Buy
44,808
+235
+0.5% +$17.7K 0.6% 60
2015
Q3
$2.98M Buy
44,573
+2,941
+7% +$217K 0.56% 63
2015
Q2
$3.08M Buy
41,632
+392
+1% +$29.9K 0.57% 61
2015
Q1
$3.22M Buy
41,240
+34,601
+521% +$2.62M 0.59% 61
2014
Q4
$479K Buy
6,639
+1,238
+23% +$86K 0.17% 117
2014
Q3
$335K Buy
5,401
+225
+4% +$14.3K 0.14% 127
2014
Q2
$330K Buy
5,176
+637
+14% +$38.7K 0.14% 123
2014
Q1
$279K Buy
+4,539
New +$264K 0.13% 128

Other funds holding MDT

SVA Wealth Management's MDT Position: Q4 2020 in Review

SVA Wealth Management reduced its Medtronic (MDT) stake by 8.3% in Q4 2020, selling an estimated $348K and leaving 35,116 shares worth $4.11M. The position accounts for 0.36% of the portfolio, ranked #56.

SVA Wealth Management first reported a position in MDT in Q1 2014 and has held it in 28 quarters since. The position peaked at $6.89M in Q1 2019. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • SVA Wealth Management held 35,116 shares of Medtronic worth $4.11M as of Q4 2020.
  • SVA Wealth Management sold 3,161 Medtronic shares in Q4 2020, an estimated $348K.
  • Medtronic made up 0.36% of SVA Wealth Management's portfolio in Q4 2020, its #56 holding.
  • SVA Wealth Management first reported a position in Medtronic in Q1 2014 and has held it in 28 quarters since.
  • SVA Wealth Management's Medtronic position peaked at $6.89M in Q1 2019.
  • 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on SVA Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.